NeuroSense Therapeutics
www.neurosense-tx.comAdvancing research, development and therapy for ALS and additional CNS indications. NeuroSense Therapeutics Ltd. (NASDAQ: NRSN) is a clinical stage Biotech company focusing on the development of a ground-breaking treatment for ALS patients, as well as other neurodegenerative diseases. Currently in preparations towards a Phase IIb in ALS patients in USA and Israel.
Read more
Advancing research, development and therapy for ALS and additional CNS indications. NeuroSense Therapeutics Ltd. (NASDAQ: NRSN) is a clinical stage Biotech company focusing on the development of a ground-breaking treatment for ALS patients, as well as other neurodegenerative diseases. Currently in preparations towards a Phase IIb in ALS patients in USA and Israel.
Read more
Country
State
Massachusetts
City (Headquarters)
Newton
Industry
Employees
11-50
Founded
2017
Social
Employees statistics
View all employeesPotential Decision Makers
Board Member
Email ****** @****.comPhone (***) ****-****Chairman
Email ****** @****.comPhone (***) ****-****Chief Medical Officer
Email ****** @****.comPhone (***) ****-****Member Board of Directors; Audit Committee Chair
Email ****** @****.comPhone (***) ****-****
Technologies
(23)
